Hospital News and Research

RSS

Identifying potential markers of neuroendocrine activity associated with grief

Researchers have examined what's currently known about the neuroendocrine effects of grief and whether biological factors can predict complicated or prolonged grief after the death of a loved one. The findings appear in the journal of Neuroendocrinology

5 Aug 2020

Study shows higher COVID-19 rates among minority and socioeconomically disadvantaged children

Minority and socioeconomically disadvantaged children have significantly higher rates of COVID-19 infection, a new study led by Children's National Hospital researchers shows.

5 Aug 2020

Could labs that test livestock ease covid testing backlog for people? Well … maybe.

In a heated exchange late last month on CNN's State of the Union, host Jake Tapper pressed Adm. Brett Giroir, the Health and Human Services assistant secretary who oversees COVID testing efforts for the Trump administration, on why the government isn't requiring commercial labs to increase testing capacity in order to speed turnaround time.

5 Aug 2020

Large proportion of UK healthcare workers may have already had Covid-19 infection

A large proportion of UK healthcare workers may already have been infected with Covid-19, according to new research led by the University of East Anglia in collaboration with University College London.

5 Aug 2020

Study emphasizes the importance of whole body skin evaluations in older patients

In a study of 552 adults aged 70 to 93 years old, 80% of participants had at least one skin disease that required treatment, and the most common conditions were fungal skin infections, rosacea, actinic keratosis, and eczema. ?

5 Aug 2020

Potential antibody treatment for yellow fever developed in 7 months using Rapid Response Strategy

Yellow fever, an acute viral hemorrhagic disease transmitted by infected mosquitoes, infects about 200,000 people and causes an estimated 30,000 deaths each year.

5 Aug 2020

Neutrolis announces development of first-in-class therapy to target NETs in COVID-19 patients

Neutrolis, a biotechnology company developing therapeutics that target neutrophils, the most abundant immune cells in the body, today announced the development of NTR-441, a first-in-class DNASE1L3 enzyme analog that has the potential to rapidly and systemically clear neutrophil extracellular traps for severe cases of COVID-19.

5 Aug 2020

Scientists develop new models to study molecular characteristics of lung and pancreatic cancers

Scientists at Huntsman Cancer Institute (HCI) at the University of Utah (U of U) report today the development of new models to study molecular characteristics of tumors of the lung and pancreas

5 Aug 2020

Pediatric experts outline back-to-school safety guidelines for solid organ transplant recipients

As school districts look ahead to a very different school year, pediatric infectious disease experts from across the United States convened to outline back-to-school safety guidelines for solid organ transplant (SOT) recipients.

5 Aug 2020

Treatment of unruptured intracranial aneurysms substantially reduces mortality rates

Mortality rates after treatment of unruptured intracranial aneurysms have substantially decreased in the past decade, according to new findings presented today at the Society of NeuroInterventional Surgery's (SNIS) 17th Annual Meeting.

5 Aug 2020

Osteopore announces success of its 3D-printed PCL bone implant in cranioplasty procedure

Osteopore International Pte Ltd, a Singapore-headquartered company leading the way in regenerative bone implants, is proud to announce the success of its technology in a new medical procedure that took place in Brisbane, Australia, in December last year.

5 Aug 2020

Scientists detect emergence and spread of artemisinin-resistant malaria parasites in Rwanda

Resistance to artemisinin, the main component of the current antimalarial treatments recommended by WHO, is already widespread in South-East Asia, but it had not previously been described in Africa.

5 Aug 2020

Pharmacists look at deprescribing to reduce the risk of medicine-related harm

In an article published today in Australian Prescriber, pharmacist Michelle Liacos from Alfred Health in Melbourne, and her co-authors, look at stopping medicines when they are no longer needed to reduce the risk of medicine-related harm.

5 Aug 2020

SNIS 17th Annual Meeting highlights COVID-19 and racial disparities in stroke treatment

The next frontier in neurointerventional surgery, including advances in stroke triage and management, innovations in artificial intelligence and robotics in endovascular surgery, new findings on racial disparities in stroke treatment and the neurologic impact of COVID-19 are a few of the topics that will be covered at the Society of NeuroInterventional Surgery's (SNIS) 17th Annual Meeting taking place virtually August 4-7, 2020.

5 Aug 2020

Interleukin-6 inhibitors appear to be a more effective treatment for COVID-19

New research from Boston Medical Center found that patients experiencing severe COVID-19 symptoms had improved outcomes when administered an Interleukin-6 (IL6ri) inhibitor, sarilumab or tocilizumab, given to mediate severe systemic inflammatory responses.

5 Aug 2020

Can Vitamin D help combat the coronavirus?

In a new report published in The Lancet, a team of researchers discussed the possibility that vitamin D could offer protection against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The meta-analyses of randomized controlled trials performed from 2007 to 2020.

4 Aug 2020

Hospital News and Research

Identifying potential markers of neuroendocrine activity associated with grief

Study shows higher COVID-19 rates among minority and socioeconomically disadvantaged children

Could labs that test livestock ease covid testing backlog for people? Well … maybe.

Large proportion of UK healthcare workers may have already had Covid-19 infection

Study emphasizes the importance of whole body skin evaluations in older patients

Potential antibody treatment for yellow fever developed in 7 months using Rapid Response Strategy

Neutrolis announces development of first-in-class therapy to target NETs in COVID-19 patients

Scientists develop new models to study molecular characteristics of lung and pancreatic cancers

Pediatric experts outline back-to-school safety guidelines for solid organ transplant recipients

Treatment of unruptured intracranial aneurysms substantially reduces mortality rates

Osteopore announces success of its 3D-printed PCL bone implant in cranioplasty procedure

Scientists detect emergence and spread of artemisinin-resistant malaria parasites in Rwanda

Pharmacists look at deprescribing to reduce the risk of medicine-related harm

SNIS 17th Annual Meeting highlights COVID-19 and racial disparities in stroke treatment

Interleukin-6 inhibitors appear to be a more effective treatment for COVID-19

Can Vitamin D help combat the coronavirus?

Four-compartment model for COVID-19 can help determine optimal disease suppression strategy

NCI gives 'exceptional' rating to Penn's Abramson Cancer Center

UC Riverside joins ATP-Bio to preserve a wide range of biological systems

Self-measurements using fitness watches generate insecurity and anxiousness

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News